Ernexa Therapeutics Inc. (ERNA)
$2.11-4.52%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $662,802
- Beta
- 2.65
- P/E (TTM)
- -0.11
- Short % float
- 19.77%
- Days to cover
- 1.0
- SI change
- +37.4%
- 1W
- -11.72%
- 1M
- -48.28%
- vs SPY 1W
- -11.58%
- vs SPY 1M
- -50.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ERNA?
- LOPJLB’s latest quantitative signal on Ernexa Therapeutics Inc. (ERNA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ERNA in?
- Ernexa Therapeutics Inc. (ERNA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Ernexa Therapeutics Inc. (ERNA) do?
- Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory …